Terren S. Peizer - Aug 15, 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director, 10%+ Owner
Signature
/s/ Joanne Wendy Kim, Attorney-in-Fact
Stock symbol
BIVI
Transactions as of
Aug 15, 2022
Transactions value $
$6,000,001
Form type
4
Date filed
8/16/2022, 05:11 PM
Previous filing
May 19, 2022
Next filing
Aug 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIVI Common Stock Award $6M +3.64M +18.62% $1.65 23.2M Aug 15, 2022 By Acuitas F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Warrants (right to buy) Award +7.27M 7.27M Aug 15, 2022 Common Stock 7.27M $1.82 By Acuitas F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.
F2 Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.